Results 161 to 170 of about 12,554 (221)

Safety and health-related quality of life following maternal respiratory syncytial virus (RSV) and diphtheria-tetanus-acellular pertussis (DTaP) vaccinations. [PDF]

Hum Vaccin Immunother
Kitano T, Kurosawa N, Watanabe S, Takeda K, Ishibashi S, Fukui H, Kurose S, Ikeda M, Kano M, Kanzaki G, Sado T, Ohgitani A, Yoshida S.   +12 more
europepmc   +1 more source

Safety and immunogenicity of diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed after three-dose priming in 2 months age infants: a randomized, blinded, controlled phase III clinical trial in China. [PDF]

Emerg Microbes Infect
Zhang W, Wei C, Wan P, Feng G, Wang F, Wang L, Tan J, Wang X, Wang X, Sui X, You W, Gou J, Yuan L, Zhu T, Huang H, Ma X, Wang Y.   +16 more
europepmc   +1 more source

Analysis of epidemiological characteristics and vaccine effectiveness of pertussis in Linping District, China. [PDF]

Front Public Health
Liu T, Chen Q, Ye C, Shen J, Zhu C, Yang P, Han R, Zhang C.   +7 more
europepmc   +1 more source

Limited protective immunity to respiratory syncytial virus and pertussis among adults and healthcare workers in South Korea: A seroepidemiologic study. [PDF]

Hum Vaccin Immunother
Lee G, Hyun J, Jang AY, Choi YJ, Nham E, Yoon JG, Choi MJ, Noh JY, Cheong HJ, Song JY.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

ACELLULAR PERTUSSIS VACCINES

Pediatric Clinics of North America, 2000
Although whole-cell pertussis vaccines have been highly effective in preventing whooping cough, their common and burdensome adverse reactions have spurred the development of safer alternatives. Seven acellular vaccines are licensed in one or more countries; four have been licensed thus far in the United States, and more may follow.
M D, Decker, K M, Edwards
openaire   +4 more sources

Acellular Pertussis Vaccine Booster

Pediatrics, 1993
The editors of Pediatrics have asked us to comment on the study by Pichichero et al,1 because our report of booster vaccination with this vaccine, published in Pediatrics in 1989,2 raised some questions with regard to the safety of the vaccine. The present study, with a design similar to ours, showed different and far more encouraging results: no ...
M, Blennow, M, Granstrom
openaire   +2 more sources

Pertussis vaccine controversies and acellular pertussis vaccine

The Indian Journal of Pediatrics, 2003
Pertussis still continues to cause significant morbidity and mortality worldwide. Because of the high reactogenicity of whole cell pertussis vaccine, it had evoked public controversy in several countries. In 1970 Japan abandoned use of whole cell pertussis vaccine and mounted efforts to develop better vaccine.
Raju C, Shah, Anuj R, Shah
openaire   +2 more sources

ACELLULAR PERTUSSIS VACCINES IN ADULTS

Infectious Disease Clinics of North America, 1999
The pathogenesis of pertussis, and the epidemiology and clinical manifestations of pertussis after childhood are reviewed as a background for a discussion of recent clinical trials of acellular pertussis vaccines in adults, and the vaccines' potential for routine use in adolescents and adults.
W A, Keitel, K M, Edwards
openaire   +2 more sources